Epithelial ovarian carcinoma is a significant cause of cancer mortality in women worldwide and in the United States. Epithelial ovarian cancer comprises several histological subtypes, each with distinct clinical and molecular characteristics. The natural history of this heterogeneous disease, including the cell types of origin, is poorly understood. This study applied recently developed methods for high-throughput DNA methylation profiling to characterize ovarian cancer cell lines and tumors, including representatives of three major histologies.We obtained DNA methylation profiles of 1,505 CpG sites (808 genes) in 27 primary epithelial ovarian tumors and 15 ovarian cancer cell lines. We found that the DNA methylation profiles of ovarian can...
Ovarian cancer is the most lethal gynaecological cancer. Although having good response to chemothera...
Epigenomic markers can identify tumor subtypes, but few platforms can accommodate formalin-fixed par...
Despite high responses to initial chemotherapy most patients with ovarian cancer (OC) relapse and in...
BACKGROUND:Epithelial ovarian carcinoma is a significant cause of cancer mortality in women worldwid...
Aberrant methylation of multiple promoter CpG islands could be related to the biology of ovarian tum...
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy, largely due to the lac...
Despite improved outcomes in the past 30 years, less than half of all women diagnosed with epithelia...
BACKGROUND:Hypermethylation of promoter CpG islands with associated loss of gene expression, and hyp...
<div><p>Despite improved outcomes in the past 30 years, less than half of all women diagnosed with e...
Aberrant methylation of multiple promoter CpG islands could be related to the biology of ovarian tum...
DNA methylation changes in ovarian cancer patients. In our work we studied DNA methylation changes i...
<div><p>Diagnosis and treatment of epithelial ovarian cancer is challenging due to the poor understa...
BackgroundOvarian clear cell carcinoma (OCCC) is a rare ovarian cancer histotype that tends to be re...
Background The epigenetics of ovarian carcinogenesis remains poorly described. We ha...
Background: Epigenetic gene silencing is one of the major causes of carcinogenesis. Its widespread o...
Ovarian cancer is the most lethal gynaecological cancer. Although having good response to chemothera...
Epigenomic markers can identify tumor subtypes, but few platforms can accommodate formalin-fixed par...
Despite high responses to initial chemotherapy most patients with ovarian cancer (OC) relapse and in...
BACKGROUND:Epithelial ovarian carcinoma is a significant cause of cancer mortality in women worldwid...
Aberrant methylation of multiple promoter CpG islands could be related to the biology of ovarian tum...
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy, largely due to the lac...
Despite improved outcomes in the past 30 years, less than half of all women diagnosed with epithelia...
BACKGROUND:Hypermethylation of promoter CpG islands with associated loss of gene expression, and hyp...
<div><p>Despite improved outcomes in the past 30 years, less than half of all women diagnosed with e...
Aberrant methylation of multiple promoter CpG islands could be related to the biology of ovarian tum...
DNA methylation changes in ovarian cancer patients. In our work we studied DNA methylation changes i...
<div><p>Diagnosis and treatment of epithelial ovarian cancer is challenging due to the poor understa...
BackgroundOvarian clear cell carcinoma (OCCC) is a rare ovarian cancer histotype that tends to be re...
Background The epigenetics of ovarian carcinogenesis remains poorly described. We ha...
Background: Epigenetic gene silencing is one of the major causes of carcinogenesis. Its widespread o...
Ovarian cancer is the most lethal gynaecological cancer. Although having good response to chemothera...
Epigenomic markers can identify tumor subtypes, but few platforms can accommodate formalin-fixed par...
Despite high responses to initial chemotherapy most patients with ovarian cancer (OC) relapse and in...